CAS: 59787-61-0; (3S,6S,9S,12R,15S,18S,21S,24S,30S,33S)-33-((1R,2R,E)-1-Hydroxy-2-Methylhex-4-En-1-yl)-30-((R)-1-Hydroxyethyl)-6,9,18,24-Tetraisobutyl-3,21-Diisopropyl-1,4,7,10,12,15,19,25,28-Nonamethyl-1,4,7,10,13,16,19,22,25,28,31-Undecaazacyclotritriacontan-2,5,8,11,14,17,20,23,26,29,32-Undecaone

该化合物是一种循环聚丙酸酯,主要来自抗免疫抑制剂,主要来源于抗菌剂的真菌,主要来源于抗菌剂Tlypocladium充气,在结构上与环氧磷酸A相似,但具有独特的药理特性.C环球丙醇的特点是能够抑制T细胞的活化和扩散,使其在预防器官移植排斥和治疗自成膜疾病方面具有价值.该化合物是亲脂性,影响其生物系统中的吸收和分布.该化合物在水中的溶性相对较低,但在有机溶剂中可溶性可溶性较低,这对药剂的配制十分重要.C环球球素C的行动机制涉及与百科林的结合,导致抑制T细胞信号中一种关键酶的卡氏素,从而降低内红素-2和其他细胞的产量,从而调节免疫反应.它与一些治疗应用在环球素A临床环境中具有进一步的效力.

结构式图片

上下游产品

Cyclosporin A 79217-60-0
双氢环孢菌素c 24-Tert-Butyl-30-(1-Hydroxyethyl)-33-(1-Hydroxy-2-Methylhexyl)-1,4,7,10,12,15,19,25,28-Nonamethyl-6,9,18-Tris(2-Methylpropyl)-3,21-Di(Propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-Undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-Undecone 63556-15-0

合成工艺路线路线简述

    C70H117N11O14置于盐酸体系中,用 四氢呋喃 作为反应溶剂,化学反应 300.0H,以100%的收率获得产物环孢菌素 C
    参考文献:Pseudoprolines (Pro) In Drug Design: Direct Insertion Of Pro Systems Into Cyclosporin C
    标题:Pseudoprolines (Pro) In Drug Design: Direct Insertion Of Pro Systems Into Cyclosporin C
    摘要:The Insertion Of Acetals That Exhibit Variable Structural Features Into Complex Peptides Such As Cyclosporin C (Csc) Results In Oxazolidine Derivatives (Pseudoprolines,Psi Pro) Of Tailored Physico-Chemical And Biological Properties. N,O-Acetalation Of The 2-Threonine Hydroxyl Group And The Preceding Amide Nitrogen Of Csc Is Achieved By Treating The Molecule With A Number Of Both Arylated And Non-Arylated Dimethyl Acetals. The Psi Pro-Containing Csc Derivatives Exhibit Enhanced Conformational Backbone Rigidity,As Suggested By Analytical HPLC,NMR Spectroscopy And By Kinetic Measurements On Binding With Their Receptor Protein Cyclophilin A (Cypa) That Were Not Time-Dependent. Ic50 Values For Calf-Thymus Cypa Were Obtained By Kinetic Evaluation Of Its Cis--> Trans Isomerase Activity. The Choice Of The Pam-Substituted Aryl Dimethyl Acetals Allows The Inhibitory Properties Of The Corresponding Derivatives To Be Modulated To Either Prodrugs Or Moderately Strongly Binding Cyclosporin C Derivatives.
    DOI:10.1002/1521-3765(20001201)6:23<4358::Aid-Chem4358>3.0.Co;2-W

    海关参考信息

    专利信息


    专利号:US-4396542-A
    优先权日:1980-02-14
    标 题 :Method for the total synthesis of cyclosporins, novel cyclosporins and novel intermediates and methods for their production
    发明人:WENGER ROLAND
    权利人:SANDOZ LTD
    摘要:A method for the total synthesis of cyclosporins, in particular Cyclosporin A, cyclosporins produced in accordance with the method of the invention and novel intermediates, in particular novel [1S, 2R, 3R]- and [1R, 2S, 3S]-1-nitrilo-1-carbonyl-3-methyl-2-oxy-heptanes and -hept-5-enes, employed in the method of the invention.

    专利号:US-4554351-A
    优先权日:1980-02-14
    标 题:Method for the total synthesis of cyclosporins, novel cyclosporins and novel intermediates and methods for their production
    发明人:WENGER ROLAND
    权利人:SANDOZ LTD
    摘要:A method for the total synthesis of cyclosporins, in particular Cyclosporin A, cyclosporins produced in accordance with the method of the invention and novel intermediates, in particular novel [1S, 2R, 3R]- and [1R, 2S, 3S]-1-nitrilo-1-carbonyl-3-methyl-2-oxy-heptanes and -hept-5-enes, employed in the method of the invention.

    专利号:US-5214130-A
    优先权日:1990-02-27
    标题 :Synthesis of novel immunosuppressive cyclosporin analogs with modified amino acids at position-8
    发明人:PATCHETT ARTHUR A; TAUB DAVID; GOEGELMAN ROBERT T
    权利人:MERCK & CO INC
    摘要:New immunosuppressive cyclosporin analogs are disclosed consisting of [dehydro-Ala]8 cyclosporins and derived therefrom cyclosporins having a sulfur containing amino acid at position-8.

    专利号:US-7910327-B2
    优先权日:2004-07-14
    标题:Recombinant alpha-fetoprotein and method of preparing
    发明人:BENEVOLENSKY SERGEI VLADIMIROVICH; MARCHENKO ALEXEI NIKOLAEVICH; KOZLOV DMITRY GEORGIEVICH; ZATSEPIN SERGEI SERGEEVICH; SHINGAROVA LYUDMILA NIKOLAEVNA; DUDICH IGOR VYACHESLAVOVICH; SEMENKOVA LIDIYA NIKOLAEVNA; DUDICH DMITRY IGOREVICH; TATULOV EDUARD BORISOVICH; DUDICH ELENA IVANOVNA
    权利人:BENEVOLENSKY SERGEI VLADIMIROVICH; MARCHENKO ALEXEI NIKOLAEVICH; KOZLOV DMITRY GEORGIEVICH; ZATSEPIN SERGEI SERGEEVICH; SHINGAROVA LYUDMILA NIKOLAEVNA; DUDICH IGOR VYACHESLAVOVICH; SEMENKOVA LIDIYA NIKOLAEVNA; DUDICH DMITRY IGOREVICH; TATULOV EDUARD BORISOVICH; DUDICH ELENA IVANOVNA
    摘要:The invention relates to the microbiological and medical industry, genetic engineering, biotechnology. A Saccharomyces cerevisiae yeast strain was obtained on the basis of constructing a recombinant plasmid DNA comprising a structural gene of a human alpha-fetoprotein (AFP) under the control of a regulatory promoter, providing the synthesis and production of AFP in a secreted soluble form, this AFP having activity identical or similar to the activity of a human AFP. The obtained recombinant AFP may be used as an active substance for the preparation of therapeutic agents for use in oncology, immunotherapy, cosmetology and also for the diagnosis of cancer and embryonic pathologies.

    专利号:EP-0034567-B1
    优先权日:1980-02-14
    标 题 :A method for the total synthesis of cyclosporins and novel cyclosporins

    专利号:EP-0098457-B1
    优先权日:1980-02-14
    标 题:(1s,2r,3r)- and (1r,2s,3s)-nitrilo-1-carbonyl-3-methyl-2-oxy-heptanes and -hept-5-enes useful in the total synthesis of cyclosporins and processes for their production
    台州市科瑞生物技术有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.pharm-intermediates.com
    企业联系电话:0576-88813233👤
    📞台州市科瑞生物技术有限公司 ⚠️参考联系方式
    联系人:金崇光
    电话:0576-88813233
    手机:13396860566
    传真:0576-88813233
    邮箱:sales@pharm-intermediates.com
    通信地址: 台州市开发大道东段288号
    邮编: 318000
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:台州市开发大道东段288号
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献


    1: Xu L, Li Y, Biggins JB, Bowman BR, Verdine GL, Gloer JB, Alspaugh JA, Bills GF. Identification of cyclosporin C from Amphichorda felina using a Cryptococcus neoformans differential temperature sensitivity assay. Appl Microbiol Biotechnol. 2018 Mar;102(5):2337-2350. doi: 10.1007/s00253-018-8792-0. Epub 2018 Feb 2. Cyclosporine C2 monitoring for the treatment of frequently relapsing nephrotic syndrome in children: a multicenter randomized phase II trial. Clin J Am Soc Nephrol. 2014 Feb;9(2):271-8. doi: 10.2215/CJN.13071212. Epub 2013 Nov 21.
    3: Freitas-Silva O, de Lourdes M, de Souza M, Venãncio A. Tracing fungi secondary metabolites in Brazil nuts using LC-MS/MS. Drug Metab Lett. 2011 Aug;5(3):150-5. doi: 10.1111/j.1365-2125.2009.03392.x.
    5: Bibikova MV, Darkhanova TA, Spiridonova IA, Danilenko AN, Katlinskiĭ AV. [Complex of cyclosporins produced by Tolypocladium inflatum isolated from soil sample from Buriatiia]. Antibiot Khimioter. 2009;54(9-10):6-9. Russian. Chinese. Epub 2006 Aug 2. Epub 2004 May 25. Epub 2003 Apr 25.

    合成参考文献


    参考文献:10.1128/aem.63.5.1739-1743.1997
    摘要:Moussaïf M, Jacques P, Schaarwächter P, Budzikiewicz H, Thonart P. Cyclosporin C is the main antifungal compound produced by Acremonium luzulae. Appl Environ Microbiol. 1997 May;63(5):1739–43. doi: 10.1128/aem.63.5.1739-1743.1997.
    参考文献:10.1002/chin.198720311
    摘要:TRABER R, HOFMANN H, LOOSLI H‐, PONELLE M, VON WARTBURG A. ChemInform Abstract: Novel Cyclosporins from Tolypocladium inflatum. The Cyclosporins K‐Z. ChemInform. 1987 May 19;18(20). doi: 10.1002/chin.198720311.
    参考文献:10.1021/acs.jmedchem.8b01259
    摘要:Naylor MR, Ly AM, Handford MJ, Ramos DP, Pye CR, Furukawa A, Klein VG, Noland RP, Edmondson Q, Turmon AC, Hewitt WM, Schwochert J, Townsend CE, Kelly CN, Blanco MJ, Lokey RS. Lipophilic Permeability Efficiency Reconciles the Opposing Roles of Lipophilicity in Membrane Permeability and Aqueous Solubility. J Med Chem. 2018 Dec 27;61(24):11169–82. doi: 10.1021/acs.jmedchem.8b01259.
    参考文献:10.1021/acs.jmedchem.1c00580
    摘要:Corbett KM, Ford L, Warren DB, Pouton CW, Chalmers DK. Cyclosporin Structure and Permeability: From A to Z and Beyond. J Med Chem. 2021 Sep 23;64(18):13131–51. doi: 10.1021/acs.jmedchem.1c00580.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知